Skip to content

Cardiovascular Benefits of Acai Polyphenols in Volunteers at Risk of Metabolic Syndrome

Cardiovascular Benefits of Acai in Volunteers at Risk of Metabolic Syndrome.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02292329
Acronym
AF1
Enrollment
23
Registered
2014-11-17
Start date
2014-09-30
Completion date
2015-03-31
Last updated
2016-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Keywords

flow-mediated dilation, Acai polyphenols

Brief summary

The purpose of this study is to carry out a randomized double blind controlled trial in 30 male subjects to investigate the effect of acai consumption on acute changes in vascular function, and to other cardiovascular markers. As a secondary aim the study will allow us to characterize the absorption and metabolism of acai polyphenols in humans over a 24 hour period.

Interventions

DIETARY_SUPPLEMENTControl Macronutrient matched

Macronutrient matched control in water and also prepared with banana.

DIETARY_SUPPLEMENTAcai puree, frozen blended it with banana

150g of acai fruit, frozen blended it with banana.

Sponsors

University of Reading
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male, 30-65 aged, BMI 25-35 kg/m2, Cholesterol \<8 mmol/l.

Exclusion criteria

* Female, BMI \<25 or \>35 kg/m2, Cholesterol \>8mmol l-1, elevated fasting blood sugar \> 6.5 mmols l-1 , elevated systolic blood pressure \>150 mmHg, history of stroke or heart attack within the previous 12 months, current smoking, taking lipid lowering, blood pressure lowering or anti-blood clotting medication or taking micronutrient supplements.

Design outcomes

Primary

MeasureTime frame
Flow-mediated dilationChange from baseline to 2h

Secondary

MeasureTime frame
plasma polyphenol metabolitesChange from baseline to 24h

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026